Skip to content
Medical Health Aged Care, Youth

New research focus on paediatric palliative care

Palliative Care Australia 2 mins read

Children, young people, and families living with life-limiting conditions are at the heart of a new research initiative announced by the Commonwealth Government. 

The Centre of Research Excellence in Paediatric Palliative Care in Australia has been funded with a $3 million grant from the Australian National Health and Medical Research Council (NHMRC). 

“This is very welcome news and will help support better planning and service delivery for the estimated 40,000 children who could benefit from palliative care each year,” says Camilla Rowland, Chief Executive Officer, Palliative Care Australia (PCA)   

The Paediatric Palliative Care National Action Plan identified the need and value in taking this coordinated approach and consolidating the sector’s existing and future research under one umbrella.

“What comes with that is a critical mass of the best research and information that is connected across state and territory borders with the sole aim of enhancing the safety and quality of care for some of our communities most precious people.”

The new Centre of Research Excellence will be led by QUT (Queensland University of Technology) under Chief investigator, Professor Natalie Bradford from the  School of Nursing at and the Cancer and Palliative Care Outcomes Centre. 

Palliative Care Australia’s Paediatric Palliative Care Manager, Annette Vickery will be an Associate Investigator, building on her four-year commitment to the Paediatric Palliative Care National Action Plan Project.

Other supporting organisations include:  

  • University of New South Wales 

  • Royal Children’s Hospital Melbourne 

  • International Children’s Palliative Care Network 

  • Children’s Health Queensland Hospital and Health Service 

  • Sydney Children’s Hospitals Network 

  • Flinders University  

“Children referred to paediatric palliative care have diverse, complex disease and accompanying needs and are often referred late,” says Professor Bradford. 

“We want to ensure high quality of care is available to all families who need it, regardless of where they live.” 

One of the strengths of the Paediatric Palliative Care National Action Plan, was the involvement of people with lived experience in shaping the four priority areas for action. 

“Funding for the Centre of Research Excellence is a direct response to what we heard from the families and health professionals we consulted with, this is action 4.3 in the plan to be precise, and it’s a credit to those people that the government has heard their advice,” says Ms Rowland. 

“The voice of lived experience will also be central to the work QUT will now lead.” 

Working closely with researchers, health and consumer organisations, the new Centre of Research Excellence will generate and share knowledge about: 

  • Models of care appropriate for geographically dispersed and diverse populations of children and families 

  • New approaches to shared decision-making that integrate the perspectives of children, family members and clinicians to ensure care in line with child and family goals and wishes 

  • Methods to measure children’s and their families’ experience and outcomes 

 “PCA looks forward to supporting this important work,” Ms Rowland says. 


Contact details:

Ian Campbell

P: 0417 482 171

E: [email protected]

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.